DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01693081 (ClinicalTrials.gov)	March 2007	21/9/2012	Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease	A Clinic-Based, Phase IIa, Double-Blind, Placebo- Controlled, Ascending-Dose, Multicentre Study of Safety, Tolerability, Efficacy and Pharmacokinetics of VR040 in Parkinson's Disease	Parkinson's Disease	Drug: VR040/Aspirair® inhaler;Drug: placebo	South Glasgow University Hospitals NHS Trust	Vectura Limited	Completed	30 Years	90 Years	Both	47	Phase 2	Serbia;United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01693081
(ClinicalTrials.gov)

March 2007

21/9/2012

Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease

A Clinic-Based, Phase IIa, Double-Blind, Placebo- Controlled, Ascending-Dose, Multicentre Study of Safety, Tolerability, Efficacy and Pharmacokinetics of VR040 in Parkinson's Disease

Parkinson's Disease

Drug: VR040/Aspirair® inhaler;Drug: placebo

South Glasgow University Hospitals NHS Trust

Vectura Limited

Completed

30 Years

90 Years

Both

Phase 2

Serbia;United Kingdom